Search Results - "Callanan, Mary"
-
1
BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer
Published in Biomedicines (06-02-2018)“…NFκB (Nuclear Factor- -light-chain-enhancer of activated B cells) signaling elicits global transcriptional changes by activating cognate promoters and through…”
Get full text
Journal Article -
2
Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial
Published in Blood (18-02-2021)“…[Display omitted] Ibrutinib, obinutuzumab, and venetoclax demonstrate synergy in preclinical models of mantle cell lymphoma (MCL). OAsIs (NCT02558816), a…”
Get full text
Journal Article -
3
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
Published in Cancer cell (14-02-2022)“…Chemotherapy with anti PD-1/PD-L1 antibodies has become the standard of care for patients with metastatic non-small cell lung cancer (mNSCLC). Using lung tumor…”
Get full text
Journal Article -
4
The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells
Published in Nature cell biology (01-11-2010)“…The initiation of DNA synthesis is governed by the licensing of replication origins, which consists of assembling a pre-replication complex (pre-RC) on origins…”
Get full text
Journal Article -
5
CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL
Published in Cancer research (Chicago, Ill.) (01-03-2017)“…Tumor-infiltrating neutrophils have been implicated in malignant development and progression, but mechanisms are ill defined. Neutrophils produce a…”
Get full text
Journal Article -
6
The secret message of heterochromatin: new insights into the mechanisms and function of centromeric and pericentric repeat sequence transcription
Published in The International journal of developmental biology (2009)“…In the fission yeast, S. Pombe, small dsRNA generated by RNAi-dependent mechanisms are involved in the establishment and maintenance of heterochromatic…”
Get full text
Journal Article -
7
Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer
Published in Cancers (27-12-2022)“…Stage II colon cancer (CC), although diagnosed early, accounts for 16% of CC deaths. Predictors of recurrence risk could mitigate this but are currently…”
Get full text
Journal Article -
8
transcriptomic analysis of human centromeric and pericentric sequences in normal and tumor cells
Published in Nucleic acids research (01-10-2009)“…Although there is now evidence that the expression of centromeric (CT) and pericentric (PCT) sequences are key players in major genomic functions, their…”
Get full text
Journal Article -
9
Identification of a novel BET bromodomain inhibitor‐sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers
Published in EMBO molecular medicine (01-08-2013)“…Immuno‐chemotherapy elicit high response rates in B‐cell non‐Hodgkin lymphoma but heterogeneity in response duration is observed, with some patients achieving…”
Get full text
Journal Article -
10
Repeat Element Activation-Driven Inflammation: Role of NFκB and Implications in Normal Development and Cancer?
Published in Biomedicines (01-12-2022)“…The human genome is composed of unique DNA sequences that encode proteins and unique sequence noncoding RNAs that are essential for normal development and…”
Get full text
Journal Article -
11
Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance
Published in Blood (25-03-2010)“…Human CD20 is a B-cell lineage–specific marker expressed by normal and leukemic B cells from the pre-B to the plasma-cell stages and is a target for rituximab…”
Get full text
Journal Article -
12
Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation
Published in Blood (04-08-2011)“…Cells of B-cell chronic lymphocytic leukemia (B-CLL) are characterized by short telomeres despite a low proliferative index. Because telomere length has been…”
Get full text
Journal Article -
13
CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL
Published in Cancers (24-11-2021)“…R-CHOP immuno-chemotherapy significantly improved clinical management of diffuse large B-cell lymphoma (DLBCL). However, 30–40% of DLBCL patients still present…”
Get full text
Journal Article -
14
A six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemia
Published in Oncotarget (30-06-2015)“…Abnormal gene expression in cancer represents an under-explored source of cancer markers and therapeutic targets. In order to identify gene expression…”
Get full text
Journal Article -
15
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow‐up Samples From Four Prospective Trials of the European MCL Network
Published in HemaSphere (01-04-2020)“…Supplemental Digital Content is available in the text Minimal residual disease (MRD) has been increasingly investigated in mantle cell lymphoma (MCL),…”
Get full text
Journal Article -
16
Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia
Published in Communications biology (20-06-2024)“…Arginine methylation is catalyzed by protein arginine methyltransferases (PRMTs) and is involved in various cellular processes, including cancer development…”
Get full text
Journal Article -
17
c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma
Published in The journal of pathology. Clinical research (01-11-2021)“…Diffuse large B‐cell lymphoma (DLBCL) is a clinically heterogeneous entity, in which the first‐line treatment currently consists of an immuno‐chemotherapy…”
Get full text
Journal Article -
18
P1090: LONG TERM FOLLOW‐UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
19
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemia
Published in EJHaem (01-02-2024)“…Risk stratification and treatment response evaluation are key features in acute myeloid leukemia (AML) management. Immunophenotypic and molecular approaches…”
Get full text
Journal Article -
20